Batistatou et al. [5] for the first time monitored ERβ expression immunohistochemically in 56 cases of astrocytomas of all grades (grade I-IV) and in adjacent non-neoplastic brain tissue. The gene discussed is ESR2; the disease is astrocytoma (excluding glioblastoma).